invest summari reiter overweight rate pt
share beat top- bottom-lin deliv better-than-
expect organ revenu growth management downplay growth
attribut easi comp time tender capit sale pull
forward reiter revenu ep guidanc think
demonstr progress toward goal fulli restor suppli get back
market growth expect highlight increment headwind
revenu ep think manag commentari set stage
believ attain guidanc
 recoveri continu top bottom-lin beat report solid top
line revenu organ slightli beat factset consensu
organ growth acceler sequenti quarter
benefit easier comp tender capit sale pull
forward report ep beat consensu
suppli fulli restor continu make progress manag
happi progress make restor full suppli see lack
full suppli impedi timelin achiev market growth
plan shift toward reduc manufactur cost simplifi
suppli chain includ reduc number sku
guidanc reiter reiter full-year guidanc
report top-lin growth ep guidanc
updat compon name fx impact tax rate expect
posit fx contribut slightli previous state rang
impli organ revenu growth midpoint
slightli higher previou midpt lower revenu
estim rais ep
estim lower ep estim
color management provid color expect organ growth
expect acceler compar like fall short
weight average market growth expect increment ep headwind
fx movement bone cement disrupt sinc call
expect portion headwind off-set lower interest expens
lower tax rate
 valuat pt base price-to-earnings ep estim
disclosur section may found page
sourc compani document factset cantor fitzgerald estim
exhibit comparison cantor estim
compani document factset cantor fitzgerald estim
inc million except per dilut inc million except per share current priorcurr priorp growth gener adminstr incom expens tax provis dilut share octob
zbh oper issu leadership uncertainti warrant discount peer
 said think zbh valuat could quickli rebound move toward histor
averag post coupl strong quarter rebuild investor confid price target
base price-to-earnings multipl ep estim
manufactur issu suppli constraint could persist resolut manufactur issu
north campu delay sever occas delay state goal
restor suppli end made signific progress
fda could take addit action fda conduct recent inspect found
observ said on-track remedi plan address old new
observ anticip fda could potenti issu warn letter take
action could neg affect zbh oper
may abl recaptur share lost meaning amount hip knee share
last two year histor share shift given year ten basi
point may abl recaptur share quickli lost
million except per share data
cost good sold
sell gener adminstr
interest expens incom
incom incom tax
sell gener adminstr
amort intang
sell gener adminstr
compani document cantor fitzgerald research
zimmer biomet headquart warsaw indiana found becam public compani august spun
bristol-my squibb june zimmer acquir biomet deal creat current zimmer biomet pure-
play orthoped compani knee revenu hip revenu make total compani sport medicin
extrem trauma spine dental sale
